Original Query: ALL
Previous Study | Return to List | Next Study

A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00057265
Recruitment Status : Completed
First Posted : March 31, 2003
Last Update Posted : March 20, 2015
Novartis Pharmaceuticals
Information provided by: